CSL News: uniQure announces FDA approval of first gene therapy for adults with hemophilia B - 23rd Nov 2022, 8:40am

annb0t

Top 20
uniQure Inc.

Lexington Facility uniQure's commercial manufacturing facility in Lexington, MA

Manufacturing State-of-the-art global commercial manufacturing at uniQure

~ Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels ~

~ uniQure conducted the multi-year clinical development program and will now leverage its leading gene therapy manufacturing...

>>> Read more: uniQure announces FDA approval of first gene therapy for adults with hemophilia B
 
Top Bottom